Adaptive 生物技术公司与辉瑞公司签署了价值高达 8.9 亿美元的非排他性协议

路透中文
Dec 15, 2025
Adaptive <a href="https://laohu8.com/S/000504">生物</a>技术公司与<a href="https://laohu8.com/S/PFE">辉瑞</a>公司签署了价值高达 8.9 亿美元的非排他性协议

路透12月15日 - Adaptive Biotechnologies ADPT.O周一表示,它已与辉瑞PFE.N签署了两项非排他性协议,以支持类风湿关节炎和其他免疫相关疾病的研究。

Adaptive公司表示,它将获得高达8.9亿美元的收入,包括前期费用和与研究进展、产品开发和销售相关的里程碑付款。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10